Marine Drugs

22 pages, 2267 KB

Open AccessArticle

Contamination Characteristics of 21 PFAS in Shellfish and Crustaceans of Zhejiang Province and Exposure Risk Assessment for Adult Dietary Consumers

by Hexiang Zhang, Haoyi Zhang, Ronghua Zhang, Dong Zhao, Bing Zhu, Xiaojuan Qi, Lili Chen, Jiang Chen, Jikai Wang, Yibin Zheng and Zhewei Feng

Mar. Drugs 2025, 23(9), 359; https://doi.org/10.3390/md23090359 - 15 Sep 2025

Abstract

This study investigated the occurrence, sources, and health risks of 21 per- and polyfluoroalkyl substances (PFAS) in commercially available shellfish and crustaceans from Zhejiang Province, China. Among the 306 samples analyzed, 87.91% contained at least one detectable PFAS. Perfluorooctanoic acid (PFOA) was the [...] Read more.

This study investigated the occurrence, sources, and health risks of 21 per- and polyfluoroalkyl substances (PFAS) in commercially available shellfish and crustaceans from Zhejiang Province, China. Among the 306 samples analyzed, 87.91% contained at least one detectable PFAS. Perfluorooctanoic acid (PFOA) was the most frequently detected PFAS (64.7%), followed by perfluorooctanesulfonic acid (PFOS) (53.8%), perfluorononanoic acid (PFNA) (52.9%), and perfluorodecanoic acid (PFDA) (50.0%). The total PFAS in shellfish and crustaceans ranged from ND to 0.86 to 173 ng/g wet weight, with a median of 4.11 ng/g ww; the concentration of total PFAS followed this order: marine crustaceans > freshwater crustaceans > bivalves > mussels. Estimation of the human intake of adult consumers, the estimated daily intake (EDI) of Σ₂₁ PFAS ranged from 0.01 to 15.7 ng/kg bw/day; 0.31% of the adult study population had Σ₄PFAS exposure levels resulting in Hazard Quotient (HQ) values > 1, which may represent a potential public health concern for these individuals. Long-term exposure risks for specific PFCAs such as perfluoroundecanoic acid (PFUdA) and perfluorotridecanoic acid (PFTrDA) merit concern. Full article

(This article belongs to the Section Marine Toxins)

► Show Figures

Graphical abstract

17 pages, 2211 KB

Open AccessArticle

Single-Cell Transcriptomic Analysis Reveals Cell Heterogeneity and Altered Signaling Pathways in Jellyfish Sting Patients

by Zhen Qin, Zhengfeng Hao, Chun Wang, Ning Lu, Peiju Qiu, Su Wang and Rilei Yu

Mar. Drugs 2025, 23(9), 358; https://doi.org/10.3390/md23090358 - 15 Sep 2025

Abstract

Jellyfish stings induce a range of symptoms, from localized irritation to life-threatening systemic reactions, yet the underlying immune mechanisms remain poorly understood. This study employed single-cell RNA sequencing (scRNA-seq) to analyze peripheral blood mononuclear cells (PBMCs) from a severely affected patient and healthy [...] Read more.

Jellyfish stings induce a range of symptoms, from localized irritation to life-threatening systemic reactions, yet the underlying immune mechanisms remain poorly understood. This study employed single-cell RNA sequencing (scRNA-seq) to analyze peripheral blood mononuclear cells (PBMCs) from a severely affected patient and healthy controls, uncovering the immune landscape at single-cell resolution and identifying the signaling pathways. We identified 11 major immune cell types, with a marked increase in CD14+ monocytes (81.86% of total cells) and significant reductions in T cells, B cells, and CD16+ monocytes in the envenomated patient. Subclustering revealed six monocyte and four neutrophil subsets, each displaying distinct functional profiles. Patient monocytes were enriched for MMP9+ and RETN+ subsets, associated with leukocyte migration and inflammation, whereas healthy controls exhibited CD74+ monocytes linked to oxidative phosphorylation. Neutrophils in the patient were predominantly LTF+ and S100A12+, implicating inflammatory and immune regulatory pathways. These findings provide a detailed single-cell atlas of immune dysregulation post-jellyfish sting, highlighting the pivotal roles of MMP9+ monocytes and S100A12+ neutrophils in driving inflammation. This study offers potential therapeutic targets for mitigating severe immune responses in jellyfish envenomation. Full article

(This article belongs to the Special Issue Celebrating the 100th Anniversary of Ocean University of China: Potential Therapeutic Benefits of Marine Novel Natural Products)

► Show Figures

Graphical abstract

17 pages, 28303 KB

Open AccessArticle

Design and Synthesis of Marine-Inspired Itampolin A Derivatives to Overcome Chemoresistance in NSCLC via Cholesterol Homeostasis Modulation

by Hai-Ying Zhang, Shun-Chang Ji, Si-Hua Xie, Yu Chen, Cai-Xia Lin, Xu Huang, Yi-Qiao Wang, Jing-Wei Liang and Yan Liu

Mar. Drugs 2025, 23(9), 357; https://doi.org/10.3390/md23090357 - 15 Sep 2025

Abstract

Recent studies on brominated tyrosine-derived marine natural products have significantly expanded the library of known structures and revealed their potent and diverse antitumor mechanisms. Building upon our previous research on the natural product itampolin A isolated from marine sponges, we conducted structural optimizations [...] Read more.

Recent studies on brominated tyrosine-derived marine natural products have significantly expanded the library of known structures and revealed their potent and diverse antitumor mechanisms. Building upon our previous research on the natural product itampolin A isolated from marine sponges, we conducted structural optimizations and explored the structure–-activity relationships (SARs) of novel scaffold derivatives concerning their inhibitory activities against lung cancer cells. In the present study, we further synthesized 15 novel derivatives, and compound 4l demonstrated selective anti-proliferative activity against gefitinib-resistant PC9/GR cells, showing 4-fold greater potency compared to parental PC9 cells. Building on this finding, the present study aims to investigate the molecular mechanisms underlying the anti-proliferative effects of 4l in drug-resistant NSCLC models. Through cell cycle analysis, apoptosis assays, and signaling pathway evaluation, we seek to establish a theoretical foundation for developing novel therapeutic agents against chemotherapy-resistant lung cancer. Full article

(This article belongs to the Special Issue Bio-Active Components from Marine Sponge)

► Show Figures

Figure 1

18 pages, 5407 KB

Open AccessArticle

Improvement Effect and Regulation Mechanism of Oyster Peptide on Dexamethasone-Induced Osteoporotic Rats

by Wei Yang, Wenyu Ma, Xiaoming Qin, Wenhong Cao and Haisheng Lin

Mar. Drugs 2025, 23(9), 356; https://doi.org/10.3390/md23090356 - 11 Sep 2025

Abstract

The increasing global population of the elderly and rising life expectancy have made osteoporosis a more severe public health issue, necessitating the development of safer and more effective therapeutic strategies. This study investigated the osteoprotective effects of low, medium, and high doses of [...] Read more.

The increasing global population of the elderly and rising life expectancy have made osteoporosis a more severe public health issue, necessitating the development of safer and more effective therapeutic strategies. This study investigated the osteoprotective effects of low, medium, and high doses of oyster peptide (OP) in dexamethasone (DEX)-induced osteoporotic rats. Pathological analysis showed that OP treatment effectively mitigated bone loss and repaired bone microarchitecture deterioration caused by DEX administration. In the OP groups, levels of the osteogenic markers osteocalcin (OCN) and osteoprotegerin (OPG) were significantly higher than in the DEX group. Moreover, levels of the osteoclastic markers RANKL, Cathepsin K (Cath-K), MMP-9, C-terminal telopeptide of type I collagen (CTX-1), and Deoxypyridine (DPD) were significantly lower. Bone proteomic analysis of the DEX and OP groups revealed that differentially expressed proteins were significantly enriched in pathways related to extracellular matrix and structural reorganization, ECM–receptor interaction, and PI3K-Akt signaling. Furthermore, virtual screening simulations indicated that peptides with lengths ranging from 11 to 20 amino acid residues were involved in modulating the activity of key receptors in these pathways, including Integrins α5β1, Integrins αvβ3, and EGFR. Collectively, these results demonstrate the significant potential of OP as a novel therapeutic agent for osteoporosis. Full article

(This article belongs to the Special Issue Marine Bioactive Peptides: Structure, Function, and Therapeutic Potential, 5th Edition)

► Show Figures

Figure 1

14 pages, 807 KB

Open AccessArticle

Phycobiliprotein Extract from Arthrospira platensis Boosts Immune Function in Pacific Oysters (Magallana gigas)

by Aleksandra Andreyeva, Tatyana Kukhareva, Anastasiya Tkachuk, Maria Podolskaya, Elina Chelebieva and Andrey Borovkov

Mar. Drugs 2025, 23(9), 355; https://doi.org/10.3390/md23090355 - 10 Sep 2025

Abstract

The utilization of functional feeds in oyster hatcheries to reduce disease-related issues and improve health in the prespawning period is expected to become essential in the near future. In the present study, an aqueous extract of phycobiliproteins (CBPs) sourced from the cyanobacterium Arthrospira [...] Read more.

The utilization of functional feeds in oyster hatcheries to reduce disease-related issues and improve health in the prespawning period is expected to become essential in the near future. In the present study, an aqueous extract of phycobiliproteins (CBPs) sourced from the cyanobacterium Arthrospira platensis was tested as an immunomodulatory agent in the Pacific oyster (Magallana gigas). Adult oysters were given three distinct treatments with the aqueous extract of CBPs (2, 20 or 80 μg/mL) for 24–96 h. In vivo analysis demonstrated that the extract of CBPs enhanced phagocytosis, lysosomal content and mitochondrial membrane potential levels, but inhibited the production of reactive oxygen species in hemocytes of oysters. Higher concentrations of the extract (80 μg/mL) had a more rapid effect on phagocytosis, with significant differences found after the first 24 h of the experiment. Lower concentrations of the extract (2 μg/mL) enhanced the phagocytic activity of hemocytes at later stages of its administration. Additionally, the expression profiles of the hsp70 and hsp90 genes were monitored in gills from oysters exposed to the extract at concentrations of 2, 20 and 200 μg/mL for 48 h, considering their roles in regulating the innate immune system in bivalves. The results show that hsp70 expression was down-regulated during the first 24 h of administration, whereas it recovered to control levels after 48 h. In contrast, the expression levels of hsp90 were up-regulated throughout the entire period of extract administration. Combined, the results of the present study show that the aqueous extract of CBPs from A. platensis can rapidly enhance the cellular immune response in Pacific oysters, and could potentially be used as an immunomodulator in bivalve hatcheries. Full article

(This article belongs to the Special Issue Immunomodulatory Activities of Marine Products)

► Show Figures

Graphical abstract

19 pages, 2207 KB

Open AccessArticle

Salinity Modulates Carbon Flux to Promote Squalene and PUFA Biosynthesis in the Marine Protist Thraustochytrium

by Yuetong Zhao, Xingyu Zhu, Nimra Riaz, Xiuping Liu, Jiaqian Li and Guangyi Wang

Mar. Drugs 2025, 23(9), 354; https://doi.org/10.3390/md23090354 - 30 Aug 2025

Abstract

Salinity is a key environmental factor regulating lipid metabolism in marine oleaginous protists. This study examined the impact of NaCl concentration on growth, glucose utilization, and lipid biosynthesis in Thraustochytrium sp. ATCC 26185. Moderate salinity (20 g/L) enhanced biomass and glucose uptake, while [...] Read more.

Salinity is a key environmental factor regulating lipid metabolism in marine oleaginous protists. This study examined the impact of NaCl concentration on growth, glucose utilization, and lipid biosynthesis in Thraustochytrium sp. ATCC 26185. Moderate salinity (20 g/L) enhanced biomass and glucose uptake, while high salinity (45 g/L) induced osmotic stress yet significantly promoted squalene accumulation (17.27 mg/g), a 3.26-fold increase compared with 0 g/L NaCl (5.29 mg/g). Integrated transcriptomic and metabolomic analyses revealed that salinity-dependent activation of glycolysis, the TCA cycle, and the pentose phosphate pathway increased cellular ATP, NADH, and NADPH levels. Under salt stress, the mevalonate (MVA) pathway was transcriptionally upregulated, with key enzymes, including ACAT, HMGR, and IDI, showing marked induction, which supports enhanced carbon flux toward squalene biosynthesis. Despite SQS downregulation, squalene accumulation increased, likely due to elevated precursor availability and reduced flux to downstream sterol pathways. Concurrently, high salinity repressed expression of ACC, FAS-α, and FAS-β, reducing saturated fatty acid levels, while upregulation of PKSB-favored polyunsaturated fatty acid (PUFA) synthesis. These findings suggest that high-salt stress triggers transcriptional reprogramming, redirecting acetyl-CoA from fatty acid synthesis toward squalene and PUFA production. This study offers new insights into the metabolic plasticity of thraustochytrids and highlights salinity modulation as a promising strategy for enhancing high-value lipid yields in marine biotechnology. Full article

(This article belongs to the Special Issue Advances in Natural Products of Marine Thraustochytrids)

► Show Figures

Figure 1

1 pages, 3790 KB

Open AccessArticle

Secondary Metabolites of the Marine Sponge-Derived Fungus Aspergillus subramanianii 1901NT-1.40.2 and Their Antimicrobial and Anticancer Activities

by Olga O. Khmel, Anton N. Yurchenko, Phan Thi Hoai Trinh, Ngo Thi Duy Ngoc, Vo Thi Dieu Trang, Huynh Hoang Nhu Khanh, Alexandr S. Antonov, Konstantin A. Drozdov, Roman S. Popov, Natalya Y. Kim, Dmitrii V. Berdyshev, Ekaterina A. Chingizova, Ekaterina S. Menchinskaya and Ekaterina A. Yurchenko

Mar. Drugs 2025, 23(9), 353; https://doi.org/10.3390/md23090353 - 30 Aug 2025

Abstract

The aim of this study was to investigate the metabolites in Aspergillus subramanianii 1901NT-1.40.2 extract using UPLC-MS, isolate and elucidate the structure of individual compounds, and study the antimicrobial and cytotoxic activities of the isolated compounds. The structures of two previously unreported ergostane [...] Read more.

The aim of this study was to investigate the metabolites in Aspergillus subramanianii 1901NT-1.40.2 extract using UPLC-MS, isolate and elucidate the structure of individual compounds, and study the antimicrobial and cytotoxic activities of the isolated compounds. The structures of two previously unreported ergostane triterpenoid aspersubrin A (1) and pyrazine alkaloid ochramide E (2) were established using NMR and HR ESI-MS. The absolute configuration of 1 was determined using quantum chemical calculations. Moreover, the known polyketides sclerolide (3) and sclerin (4); the indolediterpene alkaloid 10,23-dihydro-24,25-dehydroaflavinine (5); the bis-indolyl benzenoid alkaloids kumbicin D (6), asterriquinol D dimethyl ether (7), petromurin C (8); and the cyclopentenedione asterredione (9) were isolated. The effects of compounds 3-9 on the growth and biofilm formation of the yeast-like fungus Candida albicans and the bacteria Staphylococcus aureus and Escherichia coli were investigated. Compounds 5 and 6 inhibited C. albicans growth and biofilm formation at an IC₅₀ of 7–10 µM. Moreover, the effects of compounds 3-9 on non-cancerous H9c2 cardiomyocytes, HaCaT keratinocytes, MCF-10A breast epithelial cells, and breast cancer MCF-7 and MDA-MB-231 cells were also investigated. Compound 8 (10 µM) significantly decreased the viability of MCF-7 cells, inhibited colony formation, and arrested cell cycle progression and proliferation in monolayer culture. Moreover, 8 significantly decreased the area of MCF-7 3D spheroids by approximately 30%. A competitive test with 4-hydroxytamoxyfen and molecular docking showed that estrogen receptors (ERβ more than ERα) were involved in the anticancer effect of petromurin C (8). Full article

(This article belongs to the Collection Marine Compounds and Cancer)

► Show Figures

Figure 1

46 pages, 879 KB

Open AccessReview

Analytical Approaches to the Rapid Characterisation of Marine Glycolipids in Bioproduct Discovery

by Sudarshan Dhakal, Tim D. Nalder, Susan N. Marshall and Colin J. Barrow

Mar. Drugs 2025, 23(9), 352; https://doi.org/10.3390/md23090352 - 30 Aug 2025

Abstract

Glycolipids are structurally diverse amphiphilic molecules with potential as non-petrochemical-derived bioproducts, including surfactants, emulsifiers, and antioxidants. The different bioactivities associated with this range of glycolipid structures also present opportunities for dietary supplements, cosmetics, and pharmaceuticals. Marine glycolipids are underexplored due to challenges with [...] Read more.

Glycolipids are structurally diverse amphiphilic molecules with potential as non-petrochemical-derived bioproducts, including surfactants, emulsifiers, and antioxidants. The different bioactivities associated with this range of glycolipid structures also present opportunities for dietary supplements, cosmetics, and pharmaceuticals. Marine glycolipids are underexplored due to challenges with purification and structural characterisation. Analytical approaches enabling efficient sample purification, isolation, and identification of target glycolipids are crucial to determining the bioactivity and functions of organisms such as shellfish and seaweed. This review summarises advances in analytical methods applicable to marine glycolipids, including extraction and enrichment methods tailored to specific subclasses. Thin-layer chromatography (TLC)-based rapid detection techniques developed for specific subclasses in complex biological samples are discussed, alongside structure identification methods based on liquid chromatography (LC)–electrospray ionisation (ESI)–tandem mass spectrometry (MS/MS). Hydrophilic interaction liquid chromatography (HILIC), reverse-phase liquid chromatography (RPLC), and supercritical fluid chromatography (SFC) coupled with MS detection are reviewed for their application to glycolipids. The application of two-dimensional liquid chromatography (2D-LC) and advanced MS-based approaches that facilitate both the rapid resolution and comprehensive characterisation of molecular species are also reviewed. Full article

(This article belongs to the Special Issue From Marine Natural Products to Marine Bioproducts)

► Show Figures

Figure 1

29 pages, 3932 KB

Open AccessReview

Overview of Primary and Secondary Metabolites of Rugulopteryx okamurae Seaweed: Assessing Bioactivity, Scalability, and Molecular Mechanisms

by Ana Minerva García-Cervantes, José A. M. Prates and José Luis Guil-Guerrero

Mar. Drugs 2025, 23(9), 351; https://doi.org/10.3390/md23090351 - 30 Aug 2025

Abstract

Rugulopteryx okamurae is an invasive brown alga that has colonised Mediterranean and northeastern Atlantic coastlines, posing significant ecological and economic challenges. Its biomass is rich in structurally diverse metabolites—including polysaccharides (alginate, fucoidan, laminaran), phlorotannins, diterpenoids, fatty acids, and peptides—many of which exhibit notable [...] Read more.

Rugulopteryx okamurae is an invasive brown alga that has colonised Mediterranean and northeastern Atlantic coastlines, posing significant ecological and economic challenges. Its biomass is rich in structurally diverse metabolites—including polysaccharides (alginate, fucoidan, laminaran), phlorotannins, diterpenoids, fatty acids, and peptides—many of which exhibit notable antioxidant, anti-inflammatory, antimicrobial, and anticancer activities. Comparative assessment of extraction yields, structural features, and bioactivity data highlights phlorotannins and diterpenoids as particularly promising, demonstrating low-micromolar potencies and favourable predicted interactions with key inflammatory and apoptotic targets. Algal polysaccharides exhibit various bioactivities but hold strong potential for scalable and sustainable industrial applications. Emerging compound classes such as fatty acids and peptides display niche bioactivities; however, their structural diversity and mechanisms of action remain insufficiently explored. Insights from in vitro and in silico studies suggest that phlorotannins may modulate NF-κB and MAPK signalling pathways, while diterpenoids are implicated in the induction of mitochondrial apoptosis. Despite these findings, inconsistent extraction methodologies and a lack of in vivo pharmacokinetic and efficacy data limit translational potential. To overcome these limitations, standardized extraction protocols, detailed structure–activity relationship (SAR) and pharmacokinetic studies, and robust in vivo models are urgently needed. Bioactivity-guided valorisation strategies, aligned with ecological management, could transform R. okamurae biomass into a sustainable source for functional foods, cosmetics, and pharmaceuticals applications. Full article

(This article belongs to the Special Issue Nutritional Content, Biologically Active Compounds, and Correlated Health Impacts of Seaweed as a Resource for Nutraceutical, Cosmetic, and Pharmaceutical Applications)

► Show Figures

Graphical abstract

25 pages, 662 KB

Open AccessReview

Anti-Inflammatory and Neuroprotective Effects of Undaria pinnatifida Fucoidan

by Cheng Yang, Corinna Dwan, Barbara C. Wimmer, Sayed Koushik Ahamed, Fionnghuala James, Jigme Thinley, Richard Wilson, Luke Johnson and Vanni Caruso

Mar. Drugs 2025, 23(9), 350; https://doi.org/10.3390/md23090350 - 29 Aug 2025

Abstract

Undaria pinnatifida fucoidan (UPF), a sulphated polysaccharide derived from brown seaweed, has attracted scientific and clinical interest for its wide-ranging anti-inflammatory and neurodegenerative properties. A growing body of research shows that UPF inhibits NF-κB and MAPK signalling pathways, reduces pro-inflammatory cytokines (TNF-α, IL-1β, [...] Read more.

Undaria pinnatifida fucoidan (UPF), a sulphated polysaccharide derived from brown seaweed, has attracted scientific and clinical interest for its wide-ranging anti-inflammatory and neurodegenerative properties. A growing body of research shows that UPF inhibits NF-κB and MAPK signalling pathways, reduces pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), decreases ROS production, and suppresses iNOS and COX-2 activity, thereby mitigating oxidative and inflammatory damage in vitro. In vivo studies confirm these actions, demonstrating reduced systemic inflammation, promoted antioxidant defence, modulated gut microbiota composition, and improved production of beneficial microbial metabolites. In parallel, emerging evidence highlights UPF’s neuroprotective potential, characterised by protection against neuroinflammation and oxidative stress, the attenuation of amyloid-beta deposition, and improvement in neuronal function. Importantly, low- to medium-molecular-weight and highly sulphated UPF fractions consistently exhibit stronger bioactivities, suggesting a structural basis for its therapeutic potential. This review integrates mechanistic evidence from cellular, preclinical, and emerging clinical studies, highlighting UPF as a versatile marine-derived agent with therapeutic relevance for inflammatory and neurodegenerative diseases, and outlines future research directions toward clinical translation. Full article

(This article belongs to the Special Issue Effects of Marine Natural Products in Brain Health and Metabolic Diseases)

► Show Figures

Figure 1

20 pages, 8884 KB

Open AccessArticle

Haemostatic and Biocompatibility Evaluation of Alginate-Functionalized Polylactide Composite Containing Zinc Sulphide and Hardystonite

by Anna Kaczmarek, Zdzisława Mrozińska, Jerzy J. Chruściel, Michał Juszczak, Katarzyna Woźniak and Marcin H. Kudzin

Mar. Drugs 2025, 23(9), 349; https://doi.org/10.3390/md23090349 - 29 Aug 2025

Abstract

The aim of this study was to evaluate the haemostatic potential and biocompatibility of a newly developed composite material for its use in blood-contacting applications. Based on promising reports on polylactide (PLA), sodium alginate (ALG), and bioactive additives such as hardystonite (HT) and [...] Read more.

The aim of this study was to evaluate the haemostatic potential and biocompatibility of a newly developed composite material for its use in blood-contacting applications. Based on promising reports on polylactide (PLA), sodium alginate (ALG), and bioactive additives such as hardystonite (HT) and zinc sulphide (ZnS), a melt-blown PLA nonwoven was modified via dip-coating using an ALG solution as a matrix for incorporating HT and ZnS particles, resulting in the PLA-ALG-ZnS-HT composite. The material was characterised in terms of surface morphology, specific surface area, pore volume, average pore size, and zeta potential (pH~7.4). Haemostatic activity was assessed by measuring blood coagulation parameters, while biocompatibility was evaluated through the viability of human peripheral blood mononuclear (PBM) cells and human foreskin fibroblasts (Hs68). Genotoxicity was analysed using the comet assay and plasmid relaxation test. Results confirmed a uniform alginate coating with dispersed HT and ZnS particles on PLA fibres. The modification increased the surface area and pore volume and caused a shift toward less negative zeta potential. Haemostatic testing showed prolonged activated partial thromboplastin time (aPTT), likely due to Zn²⁺ interactions with clotting factors. Biocompatibility tests showed high cell viability and no genotoxic effects. Our findings suggest that the PLA-ALG-ZnS-HT composite is safe for blood and skin cells and may serve as an anticoagulant material. Full article

(This article belongs to the Section Biomaterials of Marine Origin)

► Show Figures

Figure 1

16 pages, 4141 KB

Open AccessArticle

Selective Utilization of Polyguluronate by the Human Gut Bacteroides Species

by Nuo Liu, Ming Li, Xiangting Yuan, Tianyu Fu, Youjing Lv and Qingsen Shang

Mar. Drugs 2025, 23(9), 348; https://doi.org/10.3390/md23090348 - 29 Aug 2025

Abstract

Human gut Bacteroides species play crucial roles in the metabolism of dietary polysaccharides. Polyguluronate (PG), a major component of alginate, has been widely used in the food and medical industries. However, how PG is utilized by human gut Bacteroides species has not been [...] Read more.

Human gut Bacteroides species play crucial roles in the metabolism of dietary polysaccharides. Polyguluronate (PG), a major component of alginate, has been widely used in the food and medical industries. However, how PG is utilized by human gut Bacteroides species has not been fully elucidated. Here, using a combination of culturomics, genomics, and state-of-the-art analytical techniques, we elucidated in detail the utilization profiles of PG by 17 different human gut Bacteroides species. Our results indicated that each Bacteroides species exhibited a unique capability for PG utilization. Among all species tested, Bacteroides xylanisolvens consumed the highest amount of PG and produced the greatest quantity of short-chain fatty acids, suggesting that it may be a keystone bacterium in PG utilization. Mass spectrometry showed that PG was degraded by B. xylanisolvens into a series of oligosaccharides. Genomic analyses confirmed that B. xylanisolvens possesses a large and divergent repertoire of carbohydrate-active enzymes. Moreover, genomic annotation identified two enzymes, PL17_2 and PL6_1, in B. xylanisolvens that are potentially responsible for PG degradation. Altogether, our study provides novel insights into PG utilization by human gut Bacteroides species, which has important implications for the development of carbohydrate-based drugs from marine resources. Full article

(This article belongs to the Special Issue Marine Algae Benefits in Pharmaceuticals, Cosmeceuticals, and Nutraceuticals)

► Show Figures

Figure 1

23 pages, 3393 KB

Open AccessReview

Unlocking the Potential of Red Seaweeds: A Special Focus on Grateloupia turuturu Yamada and Porphyra umbilicalis Kütz

by João Ferreira, Mário Pacheco, Amélia M. Silva and Isabel Gaivão

Mar. Drugs 2025, 23(9), 347; https://doi.org/10.3390/md23090347 - 29 Aug 2025

Abstract

Earth hosts a remarkable diversity of life, with oceans covering over 70% of its surface and supporting the greatest abundance and variety of species, including a vast range of seaweeds. Among these, red seaweeds (Rhodophyta) represent the most diverse group and are particularly [...] Read more.

Earth hosts a remarkable diversity of life, with oceans covering over 70% of its surface and supporting the greatest abundance and variety of species, including a vast range of seaweeds. Among these, red seaweeds (Rhodophyta) represent the most diverse group and are particularly rich in bioactive compounds. Grateloupia turuturu Yamada and Porphyra umbilicalis Kütz. are two species with significant biotechnological and functional food potential. They contain high levels of phycobiliproteins, sulfated polysaccharides (e.g., carrageenan, agar, porphyran), mycosporine-like amino acids (MAAs), phenols, minerals, and vitamins, including vitamin B12 (rare among non-animal sources). Several analytical methods, such as spectrophotometry, chromatography, and mass spectrometry, have been used to characterize their chemical composition. In vitro and in vivo studies have demonstrated their antioxidant, anti-inflammatory, neuroprotective, immunostimulatory, anti-proliferative, and photoprotective effects. These bioactive properties support its application in the food, pharmaceutical, and cosmetic sectors. Given the growing demand for sustainable resources, these algae species stand out as promising candidates for aquaculture and the development of functional ingredients. Their incorporation into novel food products, such as snacks and fortified dairy and meat products, underscores their potential to support health-promoting diets. This review highlights G. turuturu and P. umbilicalis chemical richness, bioactivities, and applications, reinforcing their value as sustainable marine resources. Full article

(This article belongs to the Special Issue Marine Algae: Unveiling Their Nutritional, Health, and Nutraceutical Potential—2nd Edition)

► Show Figures

Figure 1

18 pages, 324 KB

Open AccessReview

Harnessing Marine Algae for Sustainable Agriculture: Natural Bioactive Compounds as Eco-Friendly Pesticidal Agents

by Georgi Beev, Diyana Dermendzhieva, Zvezdelina Yaneva, Georgi Kalaydzhiev, Nikolina Naydenova, Daniela Stoeva, Denitsa Georgieva, Silviya Hristova, Zornitsa Beeva and Nikolay Petrov

Mar. Drugs 2025, 23(9), 346; https://doi.org/10.3390/md23090346 - 28 Aug 2025

Abstract

Currently, marine algae are capturing the attention of both farmers and researchers eager to integrate sustainable methods to safeguard their crops. Instead of relying exclusively on synthetic pesticides, which often have negative environmental effects, some growers are now exploring algae-based products in hopes [...] Read more.

Currently, marine algae are capturing the attention of both farmers and researchers eager to integrate sustainable methods to safeguard their crops. Instead of relying exclusively on synthetic pesticides, which often have negative environmental effects, some growers are now exploring algae-based products in hopes of reducing pest pressures. Various natural compounds sourced from algae—such as specific fatty acids and complex sugars—are believed to inhibit pest development, although their precise mechanisms are yet to be fully understood. Furthermore, there is some evidence suggesting that these compounds may bolster the plant’s own immune responses, thus enhancing crop resilience. Despite certain limitations on field applications, various techniques, including spraying, amending soil, or pre-treating seeds, are currently being evaluated. The results from the laboratory present a positive outlook, but implementing these discoveries to ensure consistent efficacy in practical settings is a major challenge. Variables such as climatic fluctuations, product durability, and formulation standards all elevate this complexity. In every instance, the approach of incorporating algae to lessen chemical dependence while securing uniform yields persists in being of interest, particularly in the area of organic or low-input farming. Full article

(This article belongs to the Section Marine Pharmacology)

18 pages, 1566 KB

Open AccessArticle

Structural and Immunological Insights into the Lipooligosaccharide of the Marine Bacterium Kangiella japonica KMM 3897

by Alina P. Filshtein, Vlada S. Belova, Alexandra S. Kuzmich, Lyudmila A. Romanenko and Maxim S. Kokoulin

Mar. Drugs 2025, 23(9), 345; https://doi.org/10.3390/md23090345 - 28 Aug 2025

Abstract

The lipooligosaccharide (LOS) of the marine bacterium Kangiella japonica KMM 3897 was structurally characterized using chemical analysis, NMR spectroscopy, and MALDI-TOF mass spectrometry. The oligosaccharide core consists of a monophosphorylated trisaccharide containing 2-amino-2-deoxy-D-glucose, D-glycero-D-manno-heptose, and 3-deoxy-D-manno-oct-2-ulosonic acid. [...] Read more.

The lipooligosaccharide (LOS) of the marine bacterium Kangiella japonica KMM 3897 was structurally characterized using chemical analysis, NMR spectroscopy, and MALDI-TOF mass spectrometry. The oligosaccharide core consists of a monophosphorylated trisaccharide containing 2-amino-2-deoxy-D-glucose, D-glycero-D-manno-heptose, and 3-deoxy-D-manno-oct-2-ulosonic acid. The penta-acylated lipid A moiety features a glucosamine disaccharide backbone with phosphate groups and amide- and ester-linked primary fatty acids [i11:0 (3-OH)], along with a secondary acyl chain (i11:0 or 11:0). Immunostimulatory assays revealed that K. japonica KMM 3897 LOS induced significantly weaker cytokine production in human peripheral blood mononuclear cells (PBMCs) compared with E. coli LPS. Notably, it exhibited potent antagonistic activity against E. coli LPS-mediated toxicity and suppressed caspase-4 activation in LPS-treated PBMCs. These findings highlight its anti-inflammatory and protective properties. Full article

(This article belongs to the Section Marine Pharmacology)

► Show Figures

Figure 1

17 pages, 5606 KB

Open AccessArticle

Implantable Bioresorbable Scaffold with Fucosylated Chondroitin Sulfate as a Promising Device for Delayed Stimulation of Hematopoiesis

by Natalia Y. Anisimova, Olga V. Rybalchenko, Natalia S. Martynenko, Georgy V. Rybalchenko, Elena A. Lukyanova, Maria I. Bilan, Anatolii I. Usov, Mikhail V. Kiselevskiy and Nikolay E. Nifantiev

Mar. Drugs 2025, 23(9), 344; https://doi.org/10.3390/md23090344 - 28 Aug 2025

Abstract

The aim of this study was to evaluate the prospects of using natural fucosylated chondroitin sulfate (FCS) from the sea cucumber Cucumaria japonica as the active component of an implantable biodegradable scaffold to stimulate hematopoiesis in mice with cyclophosphamide (CPh)-induced myelosuppression. The scaffolds [...] Read more.

The aim of this study was to evaluate the prospects of using natural fucosylated chondroitin sulfate (FCS) from the sea cucumber Cucumaria japonica as the active component of an implantable biodegradable scaffold to stimulate hematopoiesis in mice with cyclophosphamide (CPh)-induced myelosuppression. The scaffolds were based on bioresorbable Fe–Mn–C and Fe–Mn–Pd alloys after equal-channel angular pressing (ECAP). The efficiency of the developed constructs with FCS was compared with the activity of the same scaffolds loaded with recombinant human granulocyte colony stimulating factor, as well as solutions of these active compounds administered subcutaneously after the end of the cyclophosphamide (CPh) course. It was found that implantation of the Fe–Mn–C scaffold loaded with FCS most effectively stimulated hematopoiesis, providing a complex effect. This design of the developed constructs contributed to an increase in the concentration not only of leukocytes and neutrophils, but also platelets in the blood, promoted the proliferation of bone marrow cells, increasing the concentration of Ki-67(+) cells, and contributed to the restoration of the morphology of the animals’ spleen. Full article

(This article belongs to the Special Issue Biologically Active Compounds from Marine Invertebrates 2025)

► Show Figures

Figure 1

26 pages, 399 KB

Open AccessReview

Therapeutic and Nutraceutical Potential of Sargassum Species: A Narrative Review

by Alejandra Torres-Narváez, Andrea Margarita Olvera-Ramírez, Karen Castaño-Sánchez, Jorge Luis Chávez-Servín, Tércia Cesária Reis de Souza, Neil Ross McEwan and Roberto Augusto Ferriz-Martínez

Mar. Drugs 2025, 23(9), 343; https://doi.org/10.3390/md23090343 - 28 Aug 2025

Abstract

In the face of agricultural and environmental crises, the ocean and its diverse abundance of species have garnered attention as sources of beneficial compounds for humans, offering sustainable solutions across various sectors with minimal environmental impact. Sargassum, a genus of macroalgae, has [...] Read more.

In the face of agricultural and environmental crises, the ocean and its diverse abundance of species have garnered attention as sources of beneficial compounds for humans, offering sustainable solutions across various sectors with minimal environmental impact. Sargassum, a genus of macroalgae, has long been used in alternative medicine and culinary applications. This genus encompasses a wide variety of species, many of which contain bioactive compounds with significant therapeutic potential that remain under investigation. Some Sargassum species not only represent a valuable resource but also pose challenges due to their overgrowth, making their utilization both essential and strategic. In this narrative review we highlight many of the major physiological effects of these compounds, concentrating on their promising role in addressing global challenges. Full article

(This article belongs to the Special Issue Nutritional Content, Biologically Active Compounds, and Correlated Health Impacts of Seaweed as a Resource for Nutraceutical, Cosmetic, and Pharmaceutical Applications)

25 pages, 3740 KB

Open AccessReview

Microalgae-Based 3D Bioprinting: Recent Advances, Applications and Perspectives

by Jinhui Tang, Jiahui Sun, Jinyu Cui, Xiangyi Yuan, Guodong Luan and Xuefeng Lu

Mar. Drugs 2025, 23(9), 342; https://doi.org/10.3390/md23090342 - 27 Aug 2025

Abstract

Three-dimensional bioprinting integrating living cells and bioactive materials enables the fabrication of scaffold structures supporting diverse cellular growth and metabolism. Microalgae are among the most promising microbial platforms for the construction of photosynthetic cell factories, while the current industrial-scale cultivation of microalgae remains [...] Read more.

Three-dimensional bioprinting integrating living cells and bioactive materials enables the fabrication of scaffold structures supporting diverse cellular growth and metabolism. Microalgae are among the most promising microbial platforms for the construction of photosynthetic cell factories, while the current industrial-scale cultivation of microalgae remains predominantly dependent on traditional liquid submerged systems, imposing limitations on commercial viability due to both process and economic constraints. Encapsulation of microalgae within bioactive matrices combined with 3D bioprinting to fabricate customized structures has been explored to address the limitations of submerged cultivation, which are expected to expand microalgal applications and establish new research directions in microalgal biotechnology. This review analyzes both matrices and methods of 3D bioprinting, summarizing the advancement of microalgae-based 3D bioprinting into six main domains including living building materials, biophotovoltaics, photosynthetic biosynthesis, bioremediation, tissue engineering, and food engineering. Lastly, synthetic biology-informed perspectives are provided on future developments of 3D bioprinting technologies and their potential in microalgal research. Full article

(This article belongs to the Special Issue Synthetic Biology in Marine Microalgae)

► Show Figures

Graphical abstract

27 pages, 2146 KB

Open AccessArticle

Giant Moray Eel (Gymnothorax javanicus), a Long-Living Apex Predator That Poses a Food Safety Risk in the Pacific

by Emillie M. F. Passfield, Kirsty F. Smith, D. Tim Harwood, Joshua D. Fitzgerald, Phoebe A. Argyle, Jacob Thomson-Laing and J. Sam Murray

Mar. Drugs 2025, 23(9), 341; https://doi.org/10.3390/md23090341 - 26 Aug 2025

Abstract

The giant moray eel (GME; Gymnothorax javanicus) is an important marine species that plays a key ecological role in reef systems and is a valued food source for indigenous communities. However, it is well-known that GMEs pose a food safety risk due [...] Read more.

The giant moray eel (GME; Gymnothorax javanicus) is an important marine species that plays a key ecological role in reef systems and is a valued food source for indigenous communities. However, it is well-known that GMEs pose a food safety risk due to their ability to accumulate high levels of ciguatoxins (CTXs), the toxins known to cause ciguatera poisoning. This study assessed the age, CTX levels, elemental composition, and nutritional profile of seven GME specimens collected from Muri Lagoon, Rarotonga (Cook Islands), representing the most detailed compositional investigation on this species. Age was determined for the three largest specimens, with the oldest being 39 years old. All specimens contained ciguatoxins, with Type I (CTX4A derivatives), Type II (CTX3C derivatives), algal-ciguatoxins, and biotransformed metabolites being detected. There was a higher CTX content in the liver samples compared to flesh samples, with the longest–heaviest specimen containing the highest levels. The CTX1B level observed in flesh samples of all seven eel specimens exceeded the recommended safe guidance level proposed by the USFDA. A similar ciguatoxin profile was observed across flesh sections, with the belly flap or top loin containing the highest levels of CTXs in most specimens. No bioactive metabolites produced by co-occurring harmful microalgae, including regulated shellfish toxins, were detected. Elemental analysis determined the presence of 21 elements, including arsenic, low levels of mercury, and the volcanic elements rubidium and strontium. Nutritionally, the GMEs were shown to be a lean protein source; however, due to the ubiquitous bioaccumulation of CTXs, they pose a food safety risk to consumers. Full article

(This article belongs to the Section Marine Toxins)

► Show Figures

Figure 1

Journal Description

Marine Drugs

Latest Articles

Journal Menu

Journal Browser

Highly Accessed Articles

Latest Books

E-Mail Alert

News

Topics

Conferences

Special Issues

Topical Collections

Further Information

Guidelines

MDPI Initiatives

Follow MDPI